Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 1256

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 10
Chunk 1256
---
8,705,156  
    $(9,302,719) 
    $(596,232)
  
    Stock-based
    compensation 
     -  
     -  
     2,550,946  
     -  
     2,550,946 
  
    Issuance
    of common stock at IPO, net 
     1,275,000  
     128  
     7,704,152  
     -  
     7,704,279 
  
    Issuance
    of common stock conversion of debt 
     157,170  
     16  
     1,100,080  
     -  
     1,100,096 
  
    Issuance
    of common stock 
     35,715  
     4  
     249,996  
     -  
     250,000 
  
    Issuance of warrants 
     -  
     -  
     5,347,600  
     -  
     5,347,600 
  
    Net
    loss 
     -  
     -  
     -  
     (11,982,343) 
     (11,982,343)
  
    Balances,
    December 31, 2023 
     14,780,885  
     1,478  
     25,657,930  
     (21,285,062) 
     4,374,346 
  
    Balance 
     14,780,885  
     1,478  
     25,657,930  
     (21,285,062) 
     4,374,346 

    Issuance
    of common stock-ATM, net of offering costs 
     1,779,967  
     178  
     3,608,377  
     -  
     3,608,555 
  
    Payment
    of short swing disgorgement by Bay Shore Trust 
     -  
     -  
     148,703  
     -  
     148,703 
  
    Stock-based
    compensation 
     -  
     -  
     1,920,805